Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3)
Ko Yamamoto(Kyoto University), Takeshi Kimura(Municipal Hirakata City Hospital), Kyohei Yamaji(Kokura Memorial Hospital), Yasuaki Takeji(Kanazawa University), Masayuki Fuki(Tenri Hospital), Naritatsu Saito(Foundation for Biomedical Research), Ryusuke Nishikawa(Obayashi (Japan)), Hiroki Watanabe(Kyoto University), Tatsuhiko Komiya(Kurashiki Central Hospital), Junichi Tazaki(Hyogo Medical University), Kenji Minatoya(National Cerebral and Cardiovascular Center), Yutaka Furukawa(Kobe City Medical Center General Hospital), Kenji Andò(Kokura Memorial Hospital), Eri Kato(Kyoto University Hospital), Erika Yamamoto(Kyoto University), Hiroki Shiomi(Kyoto University), Yoshiharu Soga(Kokura Memorial Hospital), Hirotoshi Watanabe(Municipal Hirakata City Hospital), Kazuya Nagao(Nagaoka Red Cross Hospital), Kenji Nakatsuma(Kyoto University), Kazushige Kadota(Kurashiki Central Hospital), Yoshihisa Nakagawa(Shiga University of Medical Science), Takeshi Morimoto(Hyogo Medical University), Kazuhiro Yamazaki(Kyoto University), Masahiro Natsuaki(Saga University), Yukiko Matsumura‐Nakano(Kyoto University), Shin Watanabe(Mie University)
Cited by 21
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
|The Lancet Diabetes & Endocrinology|2019|673
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
|New England Journal of Medicine|1996|507